Iovance Biotherapeutics Inc IOVA Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	610.88M	545.92M	663.98M	824.77M	757.29M	852.32M	780.35M	869.83M
Total Current Assets	431.59M	369.88M	479.12M	637.78M	274.88M	382.59M	307.85M	385.53M
Cash and Equivalents	108.08M	118.37M	231.73M	543.48M	230.01M	267.72M	114.89M	134.19M
Total Non-Current Assets	280.44M	276.79M	290.1M	296.91M	594.96M	582.87M	586.53M	596.09M
Total Liabilities	138.19M	152.19M	164.34M	157.89M	178.72M	178.31M	195.74M	189.81M
Total Current Liabilities	64.19M	79.25M	91.49M	87.27M	88.64M	90.96M	110.31M	83.21M
Total Non-Current Liabilities	75M	73.94M	73.86M	71.61M	91.08M	88.35M	86.43M	107.59M
Common Equity	10k	10k	11k	12k	12k	14k	14k	15k
Retained Earnings	-1.36B	-1.46B	-1.57B	-1.68B	-1.78B	-1.9B	-2.01B	-2.13B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	171.89M	155.37M	480.82M	344.66M	768.46M	777.33M	663.98M	780.35M
Total Current Assets	169.51M	149.29M	475.37M	316.49M	636.1M	507.96M	479.12M	307.85M
Cash and Equivalents	106.72M	145.37M	82.15M	13.97M	67.33M	78.23M	231.73M	114.89M
Total Non-Current Assets	166.92M	145.48M	466.19M	298.97M	656.5M	621.66M	499.64M	584.61M
Total Liabilities	4.97M	9.89M	14.63M	45.68M	111.96M	155.67M	164.34M	195.74M
Total Current Liabilities	4.97M	9.89M	14.4M	39.08M	54.87M	89.2M	91.49M	110.31M
Total Non-Current Liabilities	0	0	230k	6.6M	57.09M	67.47M	73.86M	86.43M
Total Equity	166.92M	145.48M	466.19M	298.97M	656.5M	621.66M	499.64M	584.61M
Common Equity	11k	10k	11k	9k	10k	10k	11k	14k
Retained Earnings	-157.12M	-249.18M	-372.76M	-570.61M	-830.19M	-1.17B	-1.57B	-2.01B